Cardiac disorders and antidepressant medications

Journal of Psychology: Interdisciplinary and Applied

Volumn 134, Issue 2, 2000, Pages 162-168

  Murray, John B ^a  

^a ST JOHN'S UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DEPRESSION; DOSE RESPONSE; HUMAN; REVIEW; RISK FACTOR;

AGED; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CARDIOVASCULAR DISEASES; CLINICAL TRIALS; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MONOAMINE OXIDASE INHIBITORS; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 0039381871     PISSN: 00223980     EISSN: 19401019     Source Type: Journal    
DOI: 10.1080/00223980009600859     Document Type: Article

References (44)

1. APA Task Force Report. (1985). Tricyclic antidepressant-blood level measurement and clinical outcome. American Journal of Psychiatry, 142, 155-162.
2. Benfield, P., Heel, R. C., & Lewis, S. P. (1986). Fluoxetine: A review of pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs, 32,481-508.
3. Buff, D. D., Brenner, R., Kirtane, S., & Gilboa, M. (1991). Dysrhythmia associated with fluoxetine treatment in an elderly patient with cardiac disease. Journal of Clinical Psychiatry, 52, 174-176.
4. Cardiac Arrhythmia Suppression Trial (CAST). (1989). Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infection. New England Journal of Medicine, 321, 406-412.
5. Camey, R. M., Rich, M. W., Velde, A. T., Saini, J., Clark, K., & Freedland, K. E. (1988). The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease. Journal of Psychosomatic Research, 32, 159-164.
6. Cooper, G. L. (1988). The safety of fluoxetine—An update. British Journal of Psychiatry, 15(Suppl. 3), 77-86.
7. Dalack, G. W., Roose, S. P., & Glassman, A. H. (1991). Tricyclics and heart failure (letter). American Journal of Psychiatry, 148, 1601.
8. Davidson, J. (1989). Seizures and bupropion: A review. Journal of Clinical Psychiatry, 50, 256-261.
9. Dietch, J. T., & Fine, M. (1990). The effect of nortriptyline in elderly patients with cardiac conduction disease. Journal of Clinical Psychiatry, 51, 65-67.
10. Ellison, J. M., Milofsky, J. E., & Ely, E. (1990). Fluoxetine-induced bradycardia and syncope in two patients. Journal of Clinical Psychiatry, 51, 385-386.
11. Fedoroff, J. P., & Robinson, R. G. (1989). Tricyclic antidepressants in the treatment of poststroke depression. Journal of Clinical Psychiatry, 50(1 Suppl.), 8-23.
12. Fisch, C, (1985). Effect of fluoxetine on electrocardiogram. Journal of Clinical Psychiatry, 46(3, Part 2), 42-44.
13. Frasure-Smith, N., Lesperence, F., &Talajic, M. (1993). Depression following myocardial infarction: Impact on 6-month survival. Journal of the American Medical Association, 270, 1819-1825.
14. Freedland, K. E., Camey, R. M., Lustman, P. J., Rich, M. W., & Jaffe, A. S. (1992). Major depression in coronary artery disease patients with vs. without a prior history of depression. Psychosomatic Medicine, 54, 416-421.
15. Gelenberg, A. J. (1989). New perspectives on the use of tricyclic antidepressants. Journal of Clinical Psychiatry, 50(1 Suppl), 3.
16. Glassman, A. H. (1993). Cigarette smoking: Implications for psychiatric illness. American Journal of Psychiatry, 150, 546-553.
17. Glassman, A. H., & Bigger, J. T., Jr. (1981). Cardiovascular effects of therapeutic doses of tricyclic antidepressants. Archives of General Psychiatry, 38, 815-820.
18. Glassman, A. H., Giardina, E.-G. V., Perel, J., Bigger, J. T., Jr., Kantor, S. J., & Davies, M. (1979). Clinical characteristics of imipramine-induced orthostatic hypotension. Lancet, 7, 468-472.
19. Glassman, A. H., Helzer, J. E., Covey, L. S., Cottier, L. B., Stetner, F., Tipp, J. E., & Johnson, J. (1990). Smoking, smoking cessation, and major depression. Journal of the American Medical Association, 264, 1546-1549.
20. Glassman, A. H., Johnson, L. L., Giardina, E.-G. V., Walsh, B. T., Roose, S. P., Cooper, T. B., Sl Bigger, J. T., Jr. (1983). The use of imipramine in depressed patients with congestive heart failure. Journal of the Americian Medical Association, 250,1997-2000.
21. Glassman, A. H., Roose, S. P., & Bigger, J. T. (1993). The safety of tricyclic antidepressants in cardiac patients. Journal of the American Medical Association, 269, 2673-2675.
22. Glassman, A. H., & Shapiro, P. A. (1998). Depression and the course of coronary artery disease. American Journal of Psychiatry, 155,4-11.
23. Goldman, L. S., Alexander, R. C., & Luchins, D. J. (1986). Monoamine oxidase inhibitors and tricyclic antidepressants: Comparison of their cardiovascular effects. Journal of Clinical Psychiatry, 47, 225-228.
24. Halper, J. P., & Mann, J. J. (1988). Cardiovascular effects of antidepressant medication. British Journal of Psychiatry, 15J(Suppl. 3), 87-98.
25. Lipsey, J. R., Pearlson, G. D., Robinson, R. G., Rac, K., & Price, T. R. (1984). Nortriptyline treatment of poststroke depression: A double-blind study. Lancet, 1, 297-302.
26. McKim, W. A. (1997). An introduction to behavioral pharmacology (3rd ed.). Englewood Cliffs, NJ: Prentice-Hall.
27. Ostrow, D. (1985). The new generation antidepressants: Promising innovations or disappointments? Journal of Clinical Psychiatry, 46(10, Sec 2), 25-30.
28. Pollack, M. H., & Rosenbaum, J. F. (1987). Management of antidepressant-induced side effects: A practical guide for clinicians. Journal of Clinical Psychiatry, 48, 3-8.
29. Rausch, J. L., Pavlinac, D. M., & Newman, P. E. (1984). Complete heart block following a single dose of trazodone (letter). American Journal of Psychiatry, 141, 1472-1473.
30. Roose, S. P., Dalack, G. W., Glassman, A. H., Woodring, S., Walsh, B. T., & Giardina, E.G. V. (1991a). Cardiovascular effect of bupropion in depressed patients with heart disease. American Journal of Psychiatry, 148,512-516.
31. Roose, S. P., Dalack, G. W., Glassman, A. H., Woodring, S., Walsh, B. T., & Giardina, E. G. V. (1991b). Is doxepin a safer tricyclic for the heart? Journal of Clinical Psychiatry, 52, 338-341.
32. Roose, S. P., & Glassman, A. H. (1994). Antidepressant choice in the patient with cardiac disease: Lessons from the Cardiac Arrhythmia Supression Trial (CAST) studies. Journal of Clinical Psychiatry, 55(Suppl. A), 83-87.
33. Roose, S. P., Glassman, A. H., Attia, E., & Woodring, S. (1994). Comparative efficacy of selective reuptake inhibitors and tricyclics in the treatment of melancholia. American Journal of Psychiatry, 151, 1735-1739.
34. Roose, S. P., Glassman, A. H., Attia, E., Woodring, S., Giardina, E.-G. V., & Bigger, J. T. (1998). Cardiovascular effects of fluoxetine in depressed patients with heart disease. American Journal of Psychiatry, 155,660-665.
35. Roose, S. P., Glassman, A. H., & Dalack, G. W. (1989). Depression, heart disease, and tricyclic antidepressants. Journal of Clinical Psychiatry, 50(7 Suppl.), 12-16.
36. Roose, S. P., Glassman, A. H., Giardina, E.-G. V., Johnson, L. L., Walsh, B. T., Woodring, S., & Bigger, J. T., Jr. (1986). Nortriptyline in depressed patients with left ventricular impairment. Journal of the American Medical Association, 256, 3253-3257.
37. Roose, S. P., Glassman, A. H., Giardina, E.-G. V., Walsh, B. T., Woodring, S., & Bigger, J. T., Jr. (1987). Tricylic antidepressants in depressed patients with cardiac conduction disease. Archives of General Psychiatry, 44, 273-275.
38. Schleifer, S. J., Macari-Hinson, M. M., Coyle, D. A., Slater, W. R., Kahn, M., Gorlin, R., & Zucker, H. D. (1989). The nature and course of depression following myocardial infarction. Archives of Internal Medicine, 148, 1785-1789.
39. Soroko, F. E., & Maxwell, R. A. (1983). Pharmacologic basis for therapeutic interest in bupropion. Journal of Clinical Psychiatry, 44(5 Sec. 2), 67-73.
40. Tollefson, G. D. (1991). Antidepressant treatment and side effects considerations. Journal of Clinical Psychiatry, 52(5 Suppl.), 4-13.
41. Veith, R. C., Raskind, M. A., Caldwell, J. H., Barnes, R. F., Gumbrecht, G., & Ritchie, J. L. (1982). Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease. New England Journal of Medicine, 306,954-959.
42. Warrington, S. J., Padgham, C., & Lader, M. (1989). The cardiovascular effects of antidepressants. Psychological Medicine, Monograph 16, 1-32.
43. Williams, R. B., & Sherter, C. (1971). Cardiac complications of tricyclic antidepressant therapy. Annals of Internal Medicine, 74, 395-398.
44. Zung, W. W. K. (1983). Review of placebo-controlled trials of bupropion. Journal of Clinical Psychiatry, 44(5, Sec 2), 104-111.